Literature DB >> 7388055

Interaction of anthelmintic benzimidazoles with Ascaris suum embryonic tubulin.

P A Friedman, E G Platzer.   

Abstract

The ability of mebendazole and fenbendazole to bind to tubulin in cytosolic fractions from 8-day Ascaris suum embryos was determined by inhibition studies with [3H]colchicine. Colchicine binding in the presence of 1 . 10(-6) M mebendazole was completely inhibited during a 6 h incubation period at 37 degrees C. Inhibition of colchicine binding to A. suum embryonic tubulin by mebendazole and fenbendazole appeared to be noncompetitive. The inhibition constants of mebendazole and fenbendazole for A. suum embryonic tubulin were 1.9 . 10(-8) M and 6.5 . 10(-8) M, respectively. Mebendazole and fenbendazole appeared to be competitive inhibitors of colchicine binding to bovine brain tubulin. The inhibition constants of mebendazole and fenbendazole for bovine brain tubulin were 7.3 . 10(-6) M and 1.7 . 10(-5) M, respectively. These values are 250-400 times greater than the inhibition constants of fenbendazole and mebendazole for A. suum embryonic tubulin. Differential binding affinities between nematode tubulin and mammalian tubulin for benzimidazoles may explain the selective toxicity. The importance of tubulin as a receptor for anthelmintic benzimidazoles in animal parasitic nematodes is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7388055     DOI: 10.1016/0304-4165(80)90431-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Ring-testing and field-validation of a terrestrial model ecosystem (TME)--an instrument for testing potentially harmful substances: effects of carbendazim on nematodes.

Authors:  Thomas Moser; Hans-Joachim Schallnass; Susan E Jones; Cornelis A M Van Gestel; Josée E Koolhaas; José M L Rodrigues; Jörg Römbke
Journal:  Ecotoxicology       Date:  2004 Feb-Mar       Impact factor: 2.823

2.  Biochemical effects of luxabendazole on Trichinella spiralis.

Authors:  A Criado-Fornelio; C de Armas-Serra; A Jimenez-Gonzalez; N Casado-Escribano; F Rodriguez-Caabeiro
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

3.  Comparative efficacy of ketoconazole and mebendazole in experimental trichinosis.

Authors:  J A Hess; P H Chandrasekar; M Mortiere; J A Molinari
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

4.  Repositioning Flubendazole for Spinal Cord Injury.

Authors:  Chen Guang Yu; Vimala Bondada; Sarbani Ghoshal; Ranjana Singh; Christina K Pistilli; Kavi Dayaram; Hina Iqbal; Madison Sands; Kate L Davis; Subarrao Bondada; James W Geddes
Journal:  J Neurotrauma       Date:  2019-03-15       Impact factor: 5.269

5.  Interactions of Caenorhabditis elegans β-tubulins with the microtubule inhibitor and anthelmintic drug albendazole.

Authors:  Linda M Pallotto; Clayton M Dilks; Ye-Jean Park; Ryan B Smit; Brian T Lu; Chandrasekhar Gopalakrishnan; John S Gilleard; Erik C Andersen; Paul E Mains
Journal:  Genetics       Date:  2022-07-30       Impact factor: 4.402

6.  Carbendazim inhibits cancer cell proliferation by suppressing microtubule dynamics.

Authors:  Mythili Yenjerla; Corey Cox; Leslie Wilson; Mary Ann Jordan
Journal:  J Pharmacol Exp Ther       Date:  2008-11-10       Impact factor: 4.030

7.  In silico approach to screen compounds active against parasitic nematodes of major socio-economic importance.

Authors:  Varun Khanna; Shoba Ranganathan
Journal:  BMC Bioinformatics       Date:  2011-11-30       Impact factor: 3.169

8.  Efficacy of Fenbendazole and Ivermectin against Trichuris spp. in African Green Monkeys (Chlorocebus sabaeus) in Barbados West Indies.

Authors:  Kamara Rhynd; Daniel P Walsh; Linnell Cm Arthur-Banfield
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-05-10       Impact factor: 1.706

9.  Structural and functional diversity in the neuronal microtubules of Caenorhabditis elegans.

Authors:  M Chalfie; J N Thomson
Journal:  J Cell Biol       Date:  1982-04       Impact factor: 10.539

10.  Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Lydie Meheus; Vidula Sukhatme; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2014-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.